It is not suitable for pregnant women or individuals with a history of pancreatitis
As of April 7, 2025, the court has not issued a final ruling on the preliminary injunction for Semaglutide, though a related case for Tirzepatide saw a denial on March 5, 2025 (US FDA to Hold off Action)
Now map 50 units onto this schedule by concentration: 5 mg/mL: 50 units = 2.5 mg, which places you at or slightly beyond the final maintenance step 3 mg/mL: 50 units = 1.5 mg, which places you between steps 3 and 4 2.5 mg/mL: 50 units = 1.25 mg, which places you between steps 3 and 4 2 mg/mL: 50 units = 1.0 mg, which places you at step 3 Compounded semaglutide escalation patterns Compounded semaglutide follows similar escalation principles, though protocols can vary by pharmacy and prescriber
25,35 However, as Glu resembles Asp, using Asp 15 from GIP in tirzepatide should not influence its GLP-1 activity